HomeORIC • NASDAQ
add
ORIC Pharmaceuticals Inc
Previous close
$9.02
Day range
$8.69 - $9.30
Year range
$4.91 - $16.65
Market cap
617.59M USD
Avg Volume
450.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 28.99M | 12.90% |
Net income | -25.01M | -4.45% |
Net profit margin | — | — |
Earnings per share | -0.37 | 30.19% |
EBITDA | -28.73M | -13.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 316.78M | 67.05% |
Total assets | 350.79M | 54.77% |
Total liabilities | 22.14M | -7.11% |
Total equity | 328.64M | — |
Shares outstanding | 67.42M | — |
Price to book | 1.85 | — |
Return on assets | -24.05% | — |
Return on capital | -25.31% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -25.01M | -4.45% |
Cash from operations | -30.19M | -46.34% |
Cash from investing | -61.87M | -584.18% |
Cash from financing | 125.03M | — |
Net change in cash | 32.98M | 520.08% |
Free cash flow | -21.28M | -71.85% |
About
Founded
2014
Headquarters
Website
Employees
102